LAMEA AI In Drug Repurposing Market Size, Share & Industry Analysis Report By Component, By Technology, By End Use, By Application, By Country and Growth Forecast, 2025

List of Tables

The Latin America, Middle East and Africa AI In Drug Repurposing Market would witness market growth of 21.8% CAGR during the forecast period (2025-2032).

The Brazil market dominated the LAMEA AI In Drug Repurposing Market by Country in 2024, and would continue to be a dominant market till 2032; thereby, achieving a market value of $128.9 million by 2032. The Argentina market is showcasing a CAGR of 22.8% during (2025 - 2032). Additionally, The UAE market would register a CAGR of 20.6% during (2025 - 2032). The Brazil and UAE led the LAMEA AI In Drug Repurposing Market by Country with a market share of 39.4% and 13.8% in 2024. The Nigeria market is expected to witness a CAGR of 24.7% during throughout the forecast period.

AI-driven drug repurposing is growing in the LAMEA region. It started in schools and with opportunistic projects, but now it's moving toward a structured innovation ecosystem supported by the growth of digital health, the maturation of biobanks, and government-backed biotech modernization. Latin America is seeing health AI projects as part of national AI programs. Africa and the Middle East, on the other hand, are using partnerships and collaborations with global biotech companies that are funded by donors. These changes show a shift from small, separate pilot studies to focused AI applications that deal with regional disease burdens and problems with data sovereignty.

Three important trends are shaping this evolution: putting more emphasis on diseases that are common in certain areas but often ignored, using federated and privacy-preserving AI models to get around data-sharing problems, and forming strategic international partnerships to share knowledge and technology. Competition is still new and not very strong. Local startups and research institutions are focusing on niche diseases, cost-effectiveness, ease of understanding, and following local rules. Companies are increasingly looking for hybrid service-licensing models and partnerships with global players to get ready for future consolidation and to become leaders in AI-enabled drug repurposing in their regions.

Component Outlook

Based on Component, the market is segmented into Software & Platform, and Services. The Software & Platform market segment dominated the South Africa AI In Drug Repurposing Market by Component is expected to grow at a CAGR of 22.5 % during the forecast period thereby continuing its dominance until 2032. Also, The Services market is anticipated to grow as a CAGR of 23.6 % during the forecast period during (2025 - 2032).

Application Outlook

Based on Application, the market is segmented into Oncology, Neurology, Infectious Diseases, Rare & Orphan Diseases, Cardiology, and Other Application. Among various Brazil AI In Drug Repurposing Market by Application; The Oncology market achieved a market size of USD $10.1 Million in 2024 and is expected to grow at a CAGR of 19.2 % during the forecast period. The Cardiology market is predicted to experience a CAGR of 21.8% throughout the forecast period from (2025 - 2032).

Country Outlook

Brazil is the leader for AI-driven drug repurposing in Latin America. This is because it has a strong life sciences ecosystem, good academic and research institutions, and a large and diverse patient population. The country's growing digital health infrastructure, government interest in biotechnology, and large amounts of clinical data from the public health system (SUS) make it easy for AI to be used. Key opportunities exist in tackling high-burden tropical and chronic diseases via cost-effective repurposing strategies, the utilization of generative AI, and localized validation. Brazil has the potential to be a regional leader in AI-enabled drug repurposing because it has a mature scientific community, strong industrial capabilities, and new partnerships. However, there are still challenges like data fragmentation, changing regulations, and uneven infrastructure.

List of Key Companies Profiled

Ginkgo Bioworks Holdings, Inc.
IBM Corporation
Atomwise, Inc.
Cyclica, Inc.
Genesis Healthcare Co.
Verge, Inc.
Novartis AG
Schrodinger, Inc
Recursion Pharmaceuticals, Inc.
The Cradle Company

LAMEA AI In Drug Repurposing Market Report Segmentation

By Component

Software & Platform
Services

By Technology

Machine Learning/Deep Learning
Natural Language Processing (NLP)
Knowledge Graphs & Network-Based AI
Generative AI & Large Language Models (LLMs)
Computer Vision

By End Use

Pharmaceutical & BioTechnology Companies
Contract Research Organizations (CROs)
Academic & Research Institutes
Other End Use

By Application

Oncology
Neurology
Infectious Diseases
Rare & Orphan Diseases
Cardiology
Other Application

By Country

Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 LAMEA AI In Drug Repurposing Market, by Component
- 1.4.2 LAMEA AI In Drug Repurposing Market, by Technology
- 1.4.3 LAMEA AI In Drug Repurposing Market, by End Use
- 1.4.4 LAMEA AI In Drug Repurposing Market, by Application
- 1.4.5 LAMEA AI In Drug Repurposing Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. Market Trends - LAMEA AI In Drug Repurposing Market

Chapter 5. State of Competition - LAMEA AI in Drug Repurposing market

Chapter 6. Value Chain Analysis of AI In Drug Repurposing Market

Chapter 7. Product Life Cycle - AI In Drug Repurposing Market

Chapter 8. Market Consolidation - AI In Drug Repurposing Market

Chapter 9. Key Customer Criteria - AI In Drug Repurposing Market

Chapter 10. LAMEA AI In Drug Repurposing Market by Component

10.1 LAMEA Software & Platform Market by Country
10.2 LAMEA Services Market by Country

Chapter 11. LAMEA AI In Drug Repurposing Market by Technology

11.1 LAMEA Machine Learning/Deep Learning Market by Country
11.2 LAMEA Natural Language Processing (NLP) Market by Country
11.3 LAMEA Knowledge Graphs & Network-Based AI Market by Country
11.4 LAMEA Generative AI & Large Language Models (LLMs) Market by Country
11.5 LAMEA Computer Vision Market by Country

Chapter 12. LAMEA AI In Drug Repurposing Market by End Use

12.1 LAMEA Pharmaceutical & BioTechnology Companies Market by Country
12.2 LAMEA Contract Research Organizations (CROs) Market by Country
12.3 LAMEA Academic & Research Institutes Market by Country
12.4 LAMEA Other End Use Market by Country

Chapter 13. LAMEA AI In Drug Repurposing Market by Application

13.1 LAMEA Oncology Market by Country
13.2 LAMEA Neurology Market by Country
13.3 LAMEA Infectious Diseases Market by Country
13.4 LAMEA Rare & Orphan Diseases Market by Country
13.5 LAMEA Cardiology Market by Country
13.6 LAMEA Other Application Market by Country

Chapter 14. LAMEA AI In Drug Repurposing Market by Country

14.1 Brazil AI In Drug Repurposing Market
- 14.1.1 Brazil AI In Drug Repurposing Market by Component
- 14.1.2 Brazil AI In Drug Repurposing Market by Technology
- 14.1.3 Brazil AI In Drug Repurposing Market by End Use
- 14.1.4 Brazil AI In Drug Repurposing Market by Application
14.2 Argentina AI In Drug Repurposing Market
- 14.2.1 Argentina AI In Drug Repurposing Market by Component
- 14.2.2 Argentina AI In Drug Repurposing Market by Technology
- 14.2.3 Argentina AI In Drug Repurposing Market by End Use
- 14.2.4 Argentina AI In Drug Repurposing Market by Application
14.3 UAE AI In Drug Repurposing Market
- 14.3.1 UAE AI In Drug Repurposing Market by Component
- 14.3.2 UAE AI In Drug Repurposing Market by Technology
- 14.3.3 UAE AI In Drug Repurposing Market by End Use
- 14.3.4 UAE AI In Drug Repurposing Market by Application
14.4 Saudi Arabia AI In Drug Repurposing Market
- 14.4.1 Saudi Arabia AI In Drug Repurposing Market by Component
- 14.4.2 Saudi Arabia AI In Drug Repurposing Market by Technology
- 14.4.3 Saudi Arabia AI In Drug Repurposing Market by End Use
- 14.4.4 Saudi Arabia AI In Drug Repurposing Market by Application
14.5 South Africa AI In Drug Repurposing Market
- 14.5.1 South Africa AI In Drug Repurposing Market by Component
- 14.5.2 South Africa AI In Drug Repurposing Market by Technology
- 14.5.3 South Africa AI In Drug Repurposing Market by End Use
- 14.5.4 South Africa AI In Drug Repurposing Market by Application
14.6 Nigeria AI In Drug Repurposing Market
- 14.6.1 Nigeria AI In Drug Repurposing Market by Component
- 14.6.2 Nigeria AI In Drug Repurposing Market by Technology
- 14.6.3 Nigeria AI In Drug Repurposing Market by End Use
- 14.6.4 Nigeria AI In Drug Repurposing Market by Application
14.7 Rest of LAMEA AI In Drug Repurposing Market
- 14.7.1 Rest of LAMEA AI In Drug Repurposing Market by Component
- 14.7.2 Rest of LAMEA AI In Drug Repurposing Market by Technology
- 14.7.3 Rest of LAMEA AI In Drug Repurposing Market by End Use
- 14.7.4 Rest of LAMEA AI In Drug Repurposing Market by Application

Chapter 15. Company Profiles

15.1 Ginkgo Bioworks Holdings, Inc.
- 15.1.1 Company Overview
- 15.1.2 Financial Analysis
- 15.1.3 Segmental and Regional Analysis
- 15.1.4 Research & Development Expenses
- 15.1.5 Recent strategies and developments:
  - 15.1.5.1 Partnerships, Collaborations, and Agreements:
- 15.1.6 SWOT Analysis
15.2 IBM Corporation
- 15.2.1 Company Overview
- 15.2.2 Financial Analysis
- 15.2.3 Regional & Segmental Analysis
- 15.2.4 Research & Development Expenses
- 15.2.5 Recent strategies and developments:
  - 15.2.5.1 Partnerships, Collaborations, and Agreements:
- 15.2.6 SWOT Analysis
15.3 Atomwise, Inc.
- 15.3.1 Company Overview
15.4 Cyclica, Inc.
- 15.4.1 Company Overview
15.5 Genesis Healthcare Co.
- 15.5.1 Company Overview
15.6 Verge, Inc.
- 15.6.1 Company Overview
15.7 Novartis AG
- 15.7.1 Company Overview
- 15.7.2 Financial Analysis
- 15.7.3 Segmental and Regional Analysis
- 15.7.4 Research & Development Expenses
- 15.7.5 SWOT Analysis
15.8 Schrodinger, Inc
- 15.8.1 Company Overview
- 15.8.2 Financial Analysis
- 15.8.3 Segmental and Regional Analysis
- 15.8.4 Research & Development Expenses
15.9 Recursion Pharmaceuticals, Inc.
- 15.9.1 Company Overview
- 15.9.2 Financial Analysis
- 15.9.3 Research & Development Expenses
15.10. The Cradle Company
- 15.10.1 Company Overview

LIST OF TABLES

TABLE 1 LAMEA AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 2 LAMEA AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 3 Key Customer Criteria and Ratings for AI in Drug Repurposing Market
TABLE 4 LAMEA AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 5 LAMEA AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 6 LAMEA Software & Platform Market by Country, 2021 - 2024, USD Million
TABLE 7 LAMEA Software & Platform Market by Country, 2025 - 2032, USD Million
TABLE 8 LAMEA Services Market by Country, 2021 - 2024, USD Million
TABLE 9 LAMEA Services Market by Country, 2025 - 2032, USD Million
TABLE 10 LAMEA AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 11 LAMEA AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 12 LAMEA Machine Learning/Deep Learning Market by Country, 2021 - 2024, USD Million
TABLE 13 LAMEA Machine Learning/Deep Learning Market by Country, 2025 - 2032, USD Million
TABLE 14 LAMEA Natural Language Processing (NLP) Market by Country, 2021 - 2024, USD Million
TABLE 15 LAMEA Natural Language Processing (NLP) Market by Country, 2025 - 2032, USD Million
TABLE 16 LAMEA Knowledge Graphs & Network-Based AI Market by Country, 2021 - 2024, USD Million
TABLE 17 LAMEA Knowledge Graphs & Network-Based AI Market by Country, 2025 - 2032, USD Million
TABLE 18 LAMEA Generative AI & Large Language Models (LLMs) Market by Country, 2021 - 2024, USD Million
TABLE 19 LAMEA Generative AI & Large Language Models (LLMs) Market by Country, 2025 - 2032, USD Million
TABLE 20 LAMEA Computer Vision Market by Country, 2021 - 2024, USD Million
TABLE 21 LAMEA Computer Vision Market by Country, 2025 - 2032, USD Million
TABLE 22 LAMEA AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 23 LAMEA AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 24 LAMEA Pharmaceutical & BioTechnology Companies Market by Country, 2021 - 2024, USD Million
TABLE 25 LAMEA Pharmaceutical & BioTechnology Companies Market by Country, 2025 - 2032, USD Million
TABLE 26 LAMEA Contract Research Organizations (CROs) Market by Country, 2021 - 2024, USD Million
TABLE 27 LAMEA Contract Research Organizations (CROs) Market by Country, 2025 - 2032, USD Million
TABLE 28 LAMEA Academic & Research Institutes Market by Country, 2021 - 2024, USD Million
TABLE 29 LAMEA Academic & Research Institutes Market by Country, 2025 - 2032, USD Million
TABLE 30 LAMEA Other End Use Market by Country, 2021 - 2024, USD Million
TABLE 31 LAMEA Other End Use Market by Country, 2025 - 2032, USD Million
TABLE 32 LAMEA AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 33 LAMEA AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 34 LAMEA Oncology Market by Country, 2021 - 2024, USD Million
TABLE 35 LAMEA Oncology Market by Country, 2025 - 2032, USD Million
TABLE 36 LAMEA Neurology Market by Country, 2021 - 2024, USD Million
TABLE 37 LAMEA Neurology Market by Country, 2025 - 2032, USD Million
TABLE 38 LAMEA Infectious Diseases Market by Country, 2021 - 2024, USD Million
TABLE 39 LAMEA Infectious Diseases Market by Country, 2025 - 2032, USD Million
TABLE 40 LAMEA Rare & Orphan Diseases Market by Country, 2021 - 2024, USD Million
TABLE 41 LAMEA Rare & Orphan Diseases Market by Country, 2025 - 2032, USD Million
TABLE 42 LAMEA Cardiology Market by Country, 2021 - 2024, USD Million
TABLE 43 LAMEA Cardiology Market by Country, 2025 - 2032, USD Million
TABLE 44 LAMEA Other Application Market by Country, 2021 - 2024, USD Million
TABLE 45 LAMEA Other Application Market by Country, 2025 - 2032, USD Million
TABLE 46 LAMEA AI In Drug Repurposing Market by Country, 2021 - 2024, USD Million
TABLE 47 LAMEA AI In Drug Repurposing Market by Country, 2025 - 2032, USD Million
TABLE 48 Brazil AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 49 Brazil AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 50 Brazil AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 51 Brazil AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 52 Brazil AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 53 Brazil AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 54 Brazil AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 55 Brazil AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 56 Brazil AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 57 Brazil AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 58 Argentina AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 59 Argentina AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 60 Argentina AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 61 Argentina AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 62 Argentina AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 63 Argentina AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 64 Argentina AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 65 Argentina AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 66 Argentina AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 67 Argentina AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 68 UAE AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 69 UAE AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 70 UAE AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 71 UAE AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 72 UAE AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 73 UAE AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 74 UAE AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 75 UAE AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 76 UAE AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 77 UAE AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 78 Saudi Arabia AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 79 Saudi Arabia AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 80 Saudi Arabia AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 81 Saudi Arabia AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 82 Saudi Arabia AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 83 Saudi Arabia AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 84 Saudi Arabia AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 85 Saudi Arabia AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 86 Saudi Arabia AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 87 Saudi Arabia AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 88 South Africa AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 89 South Africa AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 90 South Africa AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 91 South Africa AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 92 South Africa AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 93 South Africa AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 94 South Africa AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 95 South Africa AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 96 South Africa AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 97 South Africa AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 98 Nigeria AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 99 Nigeria AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 100 Nigeria AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 101 Nigeria AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 102 Nigeria AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 103 Nigeria AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 104 Nigeria AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 105 Nigeria AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 106 Nigeria AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 107 Nigeria AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 108 Rest of LAMEA AI In Drug Repurposing Market, 2021 - 2024, USD Million
TABLE 109 Rest of LAMEA AI In Drug Repurposing Market, 2025 - 2032, USD Million
TABLE 110 Rest of LAMEA AI In Drug Repurposing Market by Component, 2021 - 2024, USD Million
TABLE 111 Rest of LAMEA AI In Drug Repurposing Market by Component, 2025 - 2032, USD Million
TABLE 112 Rest of LAMEA AI In Drug Repurposing Market by Technology, 2021 - 2024, USD Million
TABLE 113 Rest of LAMEA AI In Drug Repurposing Market by Technology, 2025 - 2032, USD Million
TABLE 114 Rest of LAMEA AI In Drug Repurposing Market by End Use, 2021 - 2024, USD Million
TABLE 115 Rest of LAMEA AI In Drug Repurposing Market by End Use, 2025 - 2032, USD Million
TABLE 116 Rest of LAMEA AI In Drug Repurposing Market by Application, 2021 - 2024, USD Million
TABLE 117 Rest of LAMEA AI In Drug Repurposing Market by Application, 2025 - 2032, USD Million
TABLE 118 Key Information - GINKGO BIOWORKS HOLDINGS, INC.
TABLE 119 Key Information - IBM Corporation
TABLE 120 Key Information - Atomwise, Inc.
TABLE 121 Key Information - Cyclica, Inc.
TABLE 122 Key Information - Genesis Healthcare Co.
TABLE 123 Key Information - Verge, Inc.
TABLE 124 Key Information - Novartis AG
TABLE 125 Key Information - Schrodinger, Inc
TABLE 126 Key Information - Recursion Pharmaceuticals, Inc.
TABLE 127 Key Information - The Cradle Company

LIST OF FIGURES

FIG 1 Methodology for the research
FIG 2 LAMEA AI In Drug Repurposing Market, 2021 - 2032, USD Million
FIG 3 Key Factors Impacting lamea AI In Drug Repurposing Market
FIG 4 Porter's Five Forces Analysis - AI In Drug Repurposing Market
FIG 5 Value Chain Analysis of AI In Drug Repurposing Market
FIG 6 Product Life Cycle - AI In Drug Repurposing Market
FIG 7 Market Consolidation - AI In Drug Repurposing Market
FIG 8 Key Customer Criteria - AI In Drug Repurposing Market
FIG 9 LAMEA AI In Drug Repurposing Market share by Component, 2024
FIG 10 LAMEA AI In Drug Repurposing Market share by Component, 2032
FIG 11 LAMEA AI In Drug Repurposing Market by Component, 2021 - 2032, USD Million
FIG 12 LAMEA AI In Drug Repurposing Market share by Technology, 2024
FIG 13 LAMEA AI In Drug Repurposing Market share by Technology, 2032
FIG 14 LAMEA AI In Drug Repurposing Market by Technology, 2021 - 2032, USD Million
FIG 15 LAMEA AI In Drug Repurposing Market share by End Use, 2024
FIG 16 LAMEA AI In Drug Repurposing Market share by End Use, 2032
FIG 17 LAMEA AI In Drug Repurposing Market by End Use, 2021 - 2032, USD Million
FIG 18 LAMEA AI In Drug Repurposing Market share by Application, 2024
FIG 19 LAMEA AI In Drug Repurposing Market share by Application, 2032
FIG 20 LAMEA AI In Drug Repurposing Market by Application, 2021 - 2032, USD Million
FIG 21 LAMEA AI In Drug Repurposing Market share by Country, 2024
FIG 22 LAMEA AI In Drug Repurposing Market share by Country, 2032
FIG 23 LAMEA AI In Drug Repurposing Market by Country, 2021 - 2032, USD Million
FIG 24 Swot Analysis: Ginkgo Bioworks
FIG 25 SWOT Analysis: IBM Corporation
FIG 26 SWOT Analysis: Novartis AG

LAMEA AI In Drug Repurposing Market Size, Share & Industry Analysis Report By Component, By Technology, By End Use, By Application, By Country and Growth Forecast, 2025 - 2032

Description

Table of Contents